Intramuscular gene transfer of FGF-2 attenuates endothelial dysfunction and inhibits intimal hyperplasia of vein grafts in poor-runoff limbs of rabbit

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 1 54-1, 2003, Pages

  Shoji, Tetsuya ^a   Yonemitsu, Yoshikazu ^a   Komori, Kimihiro ^b   Tanii, Mitsugu ^a   Itoh, Hiroyuki ^a   Sata, Shihoko ^a   Shimokawa, Hiroaki ^a   Hasegawa, Mamoru ^c   Sueishi, Katsuo ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c DNA VEC Research Inc   (Japan)

Author keywords

Fibroblast growth factor 2; Vasorelaxation; Vein graft

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; LUCIFERASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTERY BLOOD FLOW; ARTERY INTIMA PROLIFERATION; ARTICLE; COLLATERAL CIRCULATION; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; FEMORAL ARTERY; GENE TRANSFER; GRAFT FAILURE; LIMB ISCHEMIA; LIMB SALVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SENDAI VIRUS; VASCULAR ENDOTHELIUM; VASODILATATION; VEIN GRAFT; VIRUS RECOMBINANT;

EID: 0037662951     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00996.2002     Document Type: Article

References (35)

1. Alton EW, Stern M, Farley R, Jaffe A, Chadwick SL, Phillips J, Davies J, Smith SN, Browning J, Davies MG, Hodson ME, Durham SR, Li D, Jeffery PK, Scallan M, Balfour R, Eastman SJ, Cheng SH, Smith AE, Meeker D, and Geddes DM. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 353: 947-954, 1999.
2. Burger PE, Coetzee S, McKeehan WL, Kan M, Cook P, Fan Y, Suda T, Hebbel RP, Novitzky N, Muller WA, and Wilson EL. Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells. Blood 100: 3527-3535, 2002.
3. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, and Isner JM. Mouse model of angiogenesis. Am J Pathol 152: 1667-1679, 1998.
4. Epstein SE, Fuchs S, Zhou YF, Baffour R, and Kornowski R. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res 49: 532-542, 2001.
5. Epstein SE, Kornowski R, Fuchs S, and Dvorak HF. Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects. Circulation 104: 115-119, 2001.
6. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, and Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745, 2000.
7. Ikeda Y, Yonemitsu Y, Sakamoto T, Ishibashi T, Ueno H, Kato A, Nagai Y, Fukumura M, Inomata H, Hasegawa M, and Sueishi K. Recombinant Sendai virus-mediated gene transfer to the retinal tissue of adult rats: efficient gene transfer by brief exposure. Exp Eye Res 75: 39-48, 2002.
8. Inokuchi K, Kusaba A, Kamori M, Kina M, and Okadome K. Intraluminal velocity profile analyzed from flow waveforms. Surgery 92: 1006-1015, 1982.
9. Inokuchi K, Kusaba A, and Kiyose T. Flow wave form analysis in vascular surgery. Am J Surg 138: 219-223, 1979.
10. Ishida M, Komori K, Yonemitsu Y, Taguchi K, Onohara T, and Sugimachi K. Immunohistochemical phenotypic alterations of rabbit autologous vein grafts implanted under arterial circulation with or without poor distal runoff-implications of vein graft remodeling. Atherosclerosis 154: 345-354, 2001.
11. Ishii T, Okadome K, Komori K, Odashiro T, and Sugimachi K. Natural course of endothelium-dependent and -independent responses in autogenous femoral veins grafted into the arterial circulation of the dog. Circ Res 72: 1004-1010, 1993.
12. Itoh H, Komori K, Funahashi S, Okadome K, and Sugimachi K. Intimal hyperplasia of experimental autologous vein graft in hyperlipidemic rabbits with poor distal runoff. Atherosclerosis 110: 259-270, 1994.
13. Jin CH, Kusuhara K, Yonemitsu Y, Nomura A, Okano S, Takeshita H, Hasegawa M, Sueishi K, and Hara T. Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells. Gene Ther 10: 272-280, 2003.
14. Komori K, Gloviczki P, Bourchier RG, Miller VM, and Vanhoutte PM. Endothelium-dependent vasorelaxations in response to aggregating platelets are impaired in reversed vein graft. J Vasc Surg 12: 139-147, 1990.
15. Komori K, Schini VB, Gloviczki P, Bourchier RG, and Vanhoutte PM. The impairment of endothelium dependent relaxations in reversed vein grafts is associated with a reduced production of cyclic guanosine monophosphate. J Vasc Surg 14: 67-75, 1991.
16. Lowry OH, Rosenbrough NJ, Farr AL, and Randell RJ. Protein measurement with the folin reagent. J Biol Chem 193: 265-275, 1951.
17. Masaki I, Yonemitsu Y, Komori K, Ueno H, Nakashima Y, Nakagawa K, Fukumura M, Kato A, Hasan MK, Nagai Y, Sugimachi K, Hasegawa M, and Sueishi K. Recombinant Sendai virus-mediated gene transfer to vasculature: a new class of efficient gene transfer vector to the vascular system. FASEB J 15: 1294-1296, 2001.
18. Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, Nakagawa K, Hou X, Nagai Y, Hasegawa M, Sugimachi K, and Sueishi K. Gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of VEGF165, but not of FGF-2. Circ Res 90: 966-973, 2002.
19. Matsumoto T, Komori K, Yonemitsu Y, Morishita R, Sueishi K, Kaneda Y, and Sugimachi K. Hemagglutinating virus of Japan-liposome-mediated gene transfer of endothelial cell nitric oxide synthase inhibits intimal hyperplasia of canine vein grafts under conditions of poor runoff. J Vasc Surg 27: 135-144, 1998.
20. Morinaga K, Eguchi H, Miyazaki T, Okadome K, and Sugimachi K. Development and regression of intimal thickening of arterially transplanted autologous vein grafts in dogs. J Vasc Surg 5: 719-730, 1987.
21. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, and Isner JM. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578, 1998.
22. Ohta S, Komori K, Yonemitsu Y, Onohara T, Matsumoto T, and Sugimachi K. Intraluminal gene transfer of endothelial cell-nitric oxide synthase suppresses intimal hyperplasia of vein grafts in cholesterol-fed rabbit: a limited biological effect as a result of the loss of medial smooth muscle cells. Surgery 131: 644-653, 2002.
23. Okadome K, Yukizane T, Mii S, Fukuda A, and Sugimachi K. Correlation of long-term results of femoropopliteal autogenous vein grafts with shear stress variations: in situ or reversed grafts? J Cardiovasc Surg (Torino) 30: 932-935, 1989.
24. Okazaki J, Komori K, Kawasaki K, Eguchi D, Ishida M, and Sugimachi K. L-arginine inhibits smooth muscle cell proliferation of vein graft intimal thickness in hypercholesterolemic rabbits. Cardiovasc Res 36: 429-436, 1997.
25. Onohara T, Okadome K, Yamamura S, Komori K, Ishii T, Odashiro T, and Sugimachi K. Impaired endothelial prostacyclin production of the canine vein graft in a poor distal runoff limb. Surgery 113: 700-708, 1993.
26. Onohara T, Okadome K, Yamamura S, Mii S, and Sugimachi K. Simulated blood flow and the effects on prostacyclin production in the dog femoral artery. Circ Res 68: 1095-1099, 1991.
27. Onimaru M, Yonemitsu Y, Tanii M, Nakagawa K, Masaki I, Okano S, Ishibashi H, Shirasuna K, Hasegawa M, and Sueishi K. Fibroblast growth factor-2 gene transfer can stimulate endogenous hepatocyte growth factor expression, irrespective of hypoxia-mediated downregulation in ischemic limbs. Circ Res 91: 723-730, 2002.
28. Otsuka K, Takahara H, Okadome K, and Sugimachi K. Computational simulation method of intraluminal velocity profile proved by laser doppler velocimeter. J Surg Res 49: 408-412, 1990.
29. Shoji F, Yonemitsu Y, Okano S, Yoshino I, Nakagawa K, Nakashima Y, Hasegawa M, Sugimachi K, and Sueishi K. Airway-directed gene transfer of interleukin-10 using recombinant Sendai virus effectively prevents post-transplantation bronchiolitis obliterans in mice. Gene Ther 10: 213-218, 2003.
30. Taniyama Y, Morishita R, Aoki M, Nakagami H, Yamamoto K, Yamazaki K, Matsumoto K, Nakamura T, Kaneda Y, and Ogihara T. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Ther 8: 181-189, 2001.
31. Wu HM, Yuan Y, McCarthy M, and Granger HJ. Acidic and basic FGFs dilate arterioles of skeletal muscle through a NO-dependent mechanism. Am J Physiol Heart Circ Physiol 271: H1087-H1093, 1996.
32. Yamashita A, Yonemitsu Y, Okano S, Nakagawa K, Nakashima Y, Irisa T, Iwamoto Y, Nagai Y, Hasegawa M, and Sueishi K. Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats. J Immunol 168: 450-457, 2002.
33. Yonemitsu Y, Kitson C, Ferrari S, Farley R, Griesenbach U, Judd D, Steel R, Scheid P, Zhu J, Jeffery PK, Kato A, Hasan MK, Nagai Y, Masaki I, Fukumura M, Hasegawa M, Geddes DM, and Alton EW. Efficient gene transfer to the airway epithelium using recombinant Sendai virus. Nat Biotechnol 18: 970-973, 2000.
34. Yonemitsu Y, Komori K, Sueishi K, and Sugimachi K. Gene therapy in vascular surgery comes of age. Surgery 131: S261-S268, 2002.
35. Zhou M, Sutliff RL, Paul RJ, Lorenz JN, Hoying JB, Haudenschild CC, Yin M, Coffin JD, Kong L, Kranias EG, Luo W, Boivin GP, Duffy JJ, Pawlowski SA, and Doetschman T. Fibroblast growth factor 2 control of vascular tone. Nat Med 4: 201-207, 1998.